Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of...
Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure
About this item
Full title
Author / Creator
Gheorghiade, Mihai , Gattis, Wendy A. , Barbagelata, Alejandro , Adams, Kirkwood F. , Elkayam, Uri , Orlandi, Cesare , O'Connor, Christopher M. , Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators and Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure Investigators
Publisher
New York, NY: Mosby, Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York, NY: Mosby, Inc
Subjects
More information
Scope and Contents
Contents
Am Heart J 2003;145:S51-4.
Alternative Titles
Full title
Rationale and study design for a multicenter, randomized, double-blind, placebo-controlled study of the effects of tolvaptan on the acute and chronic outcomes of patients hospitalized with worsening congestive heart failure
Authors, Artists and Contributors
Author / Creator
Gattis, Wendy A.
Barbagelata, Alejandro
Adams, Kirkwood F.
Elkayam, Uri
Orlandi, Cesare
O'Connor, Christopher M.
Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators
Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure Investigators
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_73027275
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_73027275
Other Identifiers
ISSN
0002-8703
E-ISSN
1097-6744
DOI
10.1067/mhj.2003.154
